MELISSA NEYHOUSE: Open Payments
NPI 1447036918 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 78 payments from 19 companies in 2025. Trend: 2023 $505 · 2024 $2,007 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 20 | $360 |
| ABBVIE INC. | 13 | $213 |
| Insulet Corporation | 2 | $158 |
| Lilly USA, LLC | 5 | $142 |
| Madrigal Pharmaceuticals | 4 | $111 |
| Novo Nordisk Inc | 5 | $107 |
| Esperion Therapeutics, Inc. | 5 | $86 |
| GENZYME CORPORATION | 3 | $80 |
| Amgen Inc. | 4 | $78 |
| Astellas Pharma US Inc | 4 | $71 |
Products named: Kerendia, Omnipod, REZDIFFRA, VRAYLAR, ZEPBOUND, NEXLETOL, DUPIXENT, Veozah.
Industry payments across NC — which companies pay providers there.
